We are live on ! Find out more

396 hedge funds and large institutions have $1.93B invested in Chemours in 2020 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 94 increasing their positions, 147 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $1.18B → $1.93B (+$749M)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

4.68% less ownership

Funds ownership: 81.38%76.7% (-4.7%)

5% less funds holding

Funds holding: 416396 (-20)

25% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 65

36% less repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 147

66% less call options, than puts

Call options by funds: $30.2M | Put options by funds: $90M

Holders
396
Holders Change
-20
Holders Change %
-4.81%
% of All Funds
8.12%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
49
Increased
94
Reduced
147
Closed
65
Calls
$30.2M
Puts
$90M
Net Calls
-$59.8M
Net Calls Change
-$12.3M

CC Hedge Fund Activity: Q2 2020 in Review

396 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2020, worth a combined $1.93B — up 63% from $1.18B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of CC and 49 opened new positions — a net loss of 16 holders — while 147 trimmed existing stakes and 94 added.

The largest buyer was Miller Value Partners, adding an estimated $16.1M. The largest seller was Luminus Management, exiting entirely with an estimated $21.6M sold.

  • 396 institutional investors held Chemours (CC) as of Q2 2020, down from 416 in Q1 2020.
  • Funds reported $1.93B of Chemours stock for Q2 2020, up 63% quarter-over-quarter.
  • 49 funds opened new Chemours positions in Q2 2020 and 65 closed out, a net change of -16 holders.
  • The largest Chemours buyer in Q2 2020 was Miller Value Partners, an estimated $16.1M added.
  • The largest Chemours seller in Q2 2020 was Luminus Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q2 2020.